Dr. Ahmad Zamael Amin, MD

Dr. Amin practices at Northwestern Medicine Dialysis Center in Chicago, Illinois.

Dr. Amin's NPI, 1609037357, was assigned on June 24, 2008. Dr. Amin graduated from University of North Carolina School of Medicine in 2008. Dr. Amin holds Illinois license 036.130863.

Dr. Amin's primary practice is Northwestern Medicine Dialysis Center, at 676 N St Clair St 20th Fl Ste 2020, Chicago, IL 60611 in Cook County. The practice phone is (312) 472-5200.

Dr. Amin's primary practice is Northwestern Medicine Dialysis Center in Chicago, Illinois. Dr. Amin is also affiliated with Northwestern Memorial Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Amin to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Amin's employer is on file too: a dialysis center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amin practices, 5 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Amin's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Amin is board certified in dermatology by the American Board of Dermatology. Dr. Amin is licensed in Illinois.

Dmand AI lists acne, benign or precancerous skin growths, contact dermatitis, corns and calluses, hives, itchy rashes, joint cyst and psoriasis among the conditions Dr. Amin treats.

CMS data shows 2,218 Medicare services from Dr. Amin across 16 procedure codes in 2024, for 481 Medicare patients. Medicare paid $123,957 for them. Every service was in an office.

CMS counts 481 Medicare patients who saw Dr. Amin in 2024. The largest group is 65 to 74, with 272 patients. 74% of them have high cholesterol, and 59% have high blood pressure. 6% are also on Medicaid. Their average risk score is 0.91, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Amin's median patient age at 52, with 47% women.

In 2024, Dr. Amin wrote 857 Medicare Part D claims for 234 patients. 67% of them were for generic drugs. CMS names the drug for 688 of them, across 23 drugs with 11 or more claims each, at $2,196,926 in total drug cost. In 2023, CMS named 671 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Amin for performance year 2024, reported through an alternative payment model (APM). Dr. Amin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Amin as offering telehealth. CMS counts 275 procedures of removal or shaving of skin growth by Dr. Amin, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Amin, published from 2015 to 2024. 2024 was the busiest year, with 2. The most frequent topics are Hidradenitis Suppurativa, Skin Neoplasms and Urban Population. Dr. Amin has published most often in Dermatol Ther (Heidelb). Dr. Amin's most frequent co-authors are Vivek Singam, MD, Arti J. Amin, MD and Craig G. Burkhart, MD.

Dmand AI links Dr. Amin to 2 clinical trials. Conditions studied include Psoriasis and Skin Diseases, Papulosquamous. Open Payments lists research payments to Dr. Amin that name 2 trials.

CMS Open Payments shows 4,186 general payments to Dr. Amin from 31 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 82% of the total. Abbvie Inc. paid the most, $1,005,016. It also lists 3 research payments totaling $2,329 from 2018 to 2023, naming 2 clinical trials.

Dr. Amin graduated from University of North Carolina School of Medicine in 2008.

Dr. Amin is in network with 17 carriers, including Aetna, HCSC and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.